# Neuro Event Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuro-event-labs

- Industry: Software
- Headquarters: Tampere, Finland
- Website: www.neuroeventlabs.com
- Total disclosed funding: $4.3M
- Latest round: Series A (Apr 8, 2020)
- Investors on record: 3

## About

Neuro Event Labs Oy is a Finnish company specializing in advanced medical technology for the detection and analysis of seizures, offering innovative solutions to enhance patient monitoring and therapeutic interventions.Founded in 2015 and headquartered in Tampere, Finland, Neuro Event Labs Oy focuses on developing technology for seizure detection and analysis. The company has engaged in 2 deals, with the most recent occurring on April 8, 2020, when it raised EUR 3.9 million in Series A funding from Hadean Ventures, Maki.vc, and SHS Gesellschaft für Beteiligungsmanagement. The current CEO is Kaapo Annala.Neuro Event Labs specializes in advanced medical technology for the detection and analysis of seizures through its flagship product, Nelli ®. This electronic service facilitates patient data analysis and integrates with a web-based dashboard for physicians to review reports generated by machine learning algorithms. Nelli ® captures audio and video via a Personal Recording Unit (PRU), identifying events indicative of motor seizures. It is CE-marked as a class I medical device and is commercially available in the European Union, while being designated as a Breakthrough Device by the US FDA, though currently classified as investigational in the United States. The primary customers served include healthcare providers and medical institutions in the European Union and the United States, aiming to enhance clinical decision-making for patients with epilepsy.In 2023, Neuro Event Labs reported revenue of EUR 898,324.2 with an EBITDA of EUR -2,740,862.3. The company generates revenue primarily through the provision of its Nelli ® service to healthcare providers and medical institutions via subscription-based agreements, which allow continuous support and access to patient monitoring and analysis.Neuro Event Labs is targeting the development of new products and expanding its market reach. Following its Series A funding of EUR 3.9 million raised in April 2020, the company aims to enhance the Nelli ® platform and explore new geographic markets. Specific regions for expansion have not been disclosed, but the company is focusing on leveraging its recent funding to support growth initiatives and the launch of upcoming products.

## Funding rounds

- Series A, Apr 8, 2020, $4.3M — SHS Gesellschaft fur Beteiligungsmanagement, Hadean Ventures, Maki.vc

## Investors

- SHS Gesellschaft fur Beteiligungsmanagement (https://capitalatlas.ai/funds/shs-gesellschaft-fur-beteiligungsmanagement) — Series A
- Hadean Ventures (https://capitalatlas.ai/funds/hadean-ventures) — Series A
- Maki.vc (https://capitalatlas.ai/funds/maki-vc) — Series A